University of Oxford SHARP CKD-CVD outcomes model User Manual

This is a user manual for SHARP CKD-CVD outcomes model


University of Oxford SHARP CKD-CVD outcomes model User Manual - cover page
Brand
University of Oxford
Category
Healthcare software
Document type
User Manual
Language
English
Pages
27
File format
PDF
File size
2.2 MB
Published
20 October, 2023
Updated
20 October, 2023
MD5 checksum
5E12C4D312C1057D0380E165B96C0791

About this manual

This user manual describes the SHARP CKD-CVD outcomes model, a computer simulation tool developed by the University of Oxford to project health outcomes and healthcare costs for adult patients with moderate-to-severe chronic kidney disease. The model estimates risks of vascular and non-vascular mortality, major vascular events, and initiation of renal replacement therapy over 5, 10, or lifetime periods. It also evaluates life expectancy, quality-adjusted life expectancy, hospital costs, and cost-effectiveness of cardiovascular disease prevention treatments.

The model runs via a Shiny web interface using R and requires baseline patient data including age, sex, and prior disease history. Users can perform long-term projections or cost-effectiveness analyses with or without interventions. The interface supports deterministic and probabilistic sensitivity analyses, with outputs presented in .csv files including point estimates and 95% confidence intervals for key outcomes.

What's inside

  • Introduction
  • Background and aims
  • Acknowledgements
  • How to cite
  • Contact
  • References
  • Disclaimer
  • Model Interface
  • Getting started
  • Model overview

Frequently asked questions

What is the SHARP CKD-CVD outcomes model used for?

It is a computer simulation model designed to project health outcomes and healthcare costs of adult populations with moderate-to-severe chronic kidney disease (CKD), including risks of vascular or nonvascular mortality, major vascular events, and initiation of renal replacement therapy.

What patient age range is intended for use with this model?

The model is intended for use in moderate-to-severe CKD patients who are 40 years old or older.

What are the default settings for the analysis type?

The default analysis is Long-term projections without cardiovascular risk modifying intervention and without the uncertainty estimates.

What is the valid range for the number of parameter samples in a probabilistic sensitivity analysis?

For the PSA, the number of parameter samples should be specified between 100 and 1000.

Download PDF (2.2 MB)